vs
Side-by-side financial comparison of CDW Corporation (CDW) and GE HealthCare (GEHC). Click either name above to swap in a different company.
GE HealthCare is the larger business by last-quarter revenue ($5.7B vs $5.5B, roughly 1.0× CDW Corporation). On growth, GE HealthCare posted the faster year-over-year revenue change (7.1% vs 6.3%). Over the past eight quarters, GE HealthCare's revenue compounded faster (10.7% CAGR vs 6.3%).
CDW Corporation is an American multi-brand provider of information technology services, serving business, government, education, and healthcare sectors across the United States, the United Kingdom, and Canada. Headquartered in Vernon Hills, Illinois, CDW is a Fortune 500 and generated $21 billion in annual net sales in 2023.
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures...
CDW vs GEHC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.5B | $5.7B |
| Net Profit | — | $588.0M |
| Gross Margin | 22.8% | 39.7% |
| Operating Margin | 7.8% | 14.5% |
| Net Margin | — | 10.3% |
| Revenue YoY | 6.3% | 7.1% |
| Net Profit YoY | — | -18.4% |
| EPS (diluted) | $2.13 | $1.28 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.5B | $5.7B | ||
| Q3 25 | $5.7B | $5.1B | ||
| Q2 25 | $6.0B | $5.0B | ||
| Q1 25 | $5.2B | $4.8B | ||
| Q4 24 | $5.2B | $5.3B | ||
| Q3 24 | $5.5B | $4.9B | ||
| Q2 24 | $5.4B | $4.8B | ||
| Q1 24 | $4.9B | $4.7B |
| Q4 25 | — | $588.0M | ||
| Q3 25 | $291.0M | $446.0M | ||
| Q2 25 | $271.2M | $486.0M | ||
| Q1 25 | $224.9M | $564.0M | ||
| Q4 24 | — | $721.0M | ||
| Q3 24 | $316.4M | $470.0M | ||
| Q2 24 | $281.1M | $428.0M | ||
| Q1 24 | $216.1M | $374.0M |
| Q4 25 | 22.8% | 39.7% | ||
| Q3 25 | 21.9% | 38.7% | ||
| Q2 25 | 20.8% | 39.6% | ||
| Q1 25 | 21.6% | 42.1% | ||
| Q4 24 | 22.3% | 42.8% | ||
| Q3 24 | 21.8% | 41.7% | ||
| Q2 24 | 21.8% | 41.4% | ||
| Q1 24 | 21.8% | 40.9% |
| Q4 25 | 7.8% | 14.5% | ||
| Q3 25 | 7.7% | 12.7% | ||
| Q2 25 | 7.0% | 13.1% | ||
| Q1 25 | 7.0% | 13.2% | ||
| Q4 24 | 7.9% | 15.1% | ||
| Q3 24 | 8.7% | 13.9% | ||
| Q2 24 | 8.0% | 12.6% | ||
| Q1 24 | 6.7% | 11.6% |
| Q4 25 | — | 10.3% | ||
| Q3 25 | 5.1% | 8.7% | ||
| Q2 25 | 4.5% | 9.7% | ||
| Q1 25 | 4.3% | 11.8% | ||
| Q4 24 | — | 13.6% | ||
| Q3 24 | 5.7% | 9.7% | ||
| Q2 24 | 5.2% | 8.8% | ||
| Q1 24 | 4.4% | 8.0% |
| Q4 25 | $2.13 | $1.28 | ||
| Q3 25 | $2.21 | $0.98 | ||
| Q2 25 | $2.05 | $1.06 | ||
| Q1 25 | $1.69 | $1.23 | ||
| Q4 24 | $1.97 | $1.58 | ||
| Q3 24 | $2.34 | $1.02 | ||
| Q2 24 | $2.07 | $0.93 | ||
| Q1 24 | $1.59 | $0.81 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $618.7M | $4.5B |
| Total DebtLower is stronger | — | $10.0B |
| Stockholders' EquityBook value | $2.6B | $10.4B |
| Total Assets | $16.0B | $36.9B |
| Debt / EquityLower = less leverage | — | 0.96× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $618.7M | $4.5B | ||
| Q3 25 | $452.9M | $4.0B | ||
| Q2 25 | $481.0M | $3.7B | ||
| Q1 25 | $688.1M | $2.5B | ||
| Q4 24 | $717.7M | $2.9B | ||
| Q3 24 | $1.2B | $3.5B | ||
| Q2 24 | $665.3M | $2.0B | ||
| Q1 24 | $803.8M | $2.6B |
| Q4 25 | — | $10.0B | ||
| Q3 25 | — | $10.3B | ||
| Q2 25 | — | $10.3B | ||
| Q1 25 | — | $8.8B | ||
| Q4 24 | — | $9.0B | ||
| Q3 24 | — | $10.3B | ||
| Q2 24 | — | $9.2B | ||
| Q1 24 | — | $9.3B |
| Q4 25 | $2.6B | $10.4B | ||
| Q3 25 | $2.5B | $10.0B | ||
| Q2 25 | $2.5B | $9.7B | ||
| Q1 25 | $2.3B | $9.2B | ||
| Q4 24 | $2.4B | $8.4B | ||
| Q3 24 | $2.3B | $8.3B | ||
| Q2 24 | $2.2B | $7.8B | ||
| Q1 24 | $2.1B | $7.4B |
| Q4 25 | $16.0B | $36.9B | ||
| Q3 25 | $15.2B | $36.1B | ||
| Q2 25 | $15.3B | $35.5B | ||
| Q1 25 | $15.0B | $33.6B | ||
| Q4 24 | $14.7B | $33.1B | ||
| Q3 24 | $14.4B | $33.9B | ||
| Q2 24 | $13.6B | $31.9B | ||
| Q1 24 | $13.2B | $32.2B |
| Q4 25 | — | 0.96× | ||
| Q3 25 | — | 1.03× | ||
| Q2 25 | — | 1.06× | ||
| Q1 25 | — | 0.95× | ||
| Q4 24 | — | 1.06× | ||
| Q3 24 | — | 1.24× | ||
| Q2 24 | — | 1.18× | ||
| Q1 24 | — | 1.25× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $433.8M | — |
| Free Cash FlowOCF − Capex | $395.9M | — |
| FCF MarginFCF / Revenue | 7.2% | — |
| Capex IntensityCapex / Revenue | 0.7% | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.1B | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $433.8M | — | ||
| Q3 25 | $328.3M | — | ||
| Q2 25 | $155.9M | $94.0M | ||
| Q1 25 | $287.2M | $250.0M | ||
| Q4 24 | $345.3M | — | ||
| Q3 24 | $342.1M | — | ||
| Q2 24 | $149.9M | $-119.0M | ||
| Q1 24 | $440.0M | $419.0M |
| Q4 25 | $395.9M | — | ||
| Q3 25 | $298.5M | — | ||
| Q2 25 | $133.4M | $8.0M | ||
| Q1 25 | $260.3M | $98.0M | ||
| Q4 24 | $316.7M | — | ||
| Q3 24 | $308.5M | — | ||
| Q2 24 | $119.0M | $-183.0M | ||
| Q1 24 | $410.5M | $274.0M |
| Q4 25 | 7.2% | — | ||
| Q3 25 | 5.2% | — | ||
| Q2 25 | 2.2% | 0.2% | ||
| Q1 25 | 5.0% | 2.1% | ||
| Q4 24 | 6.1% | — | ||
| Q3 24 | 5.6% | — | ||
| Q2 24 | 2.2% | -3.8% | ||
| Q1 24 | 8.4% | 5.9% |
| Q4 25 | 0.7% | 2.4% | ||
| Q3 25 | 0.5% | 2.1% | ||
| Q2 25 | 0.4% | 1.7% | ||
| Q1 25 | 0.5% | 3.2% | ||
| Q4 24 | 0.6% | 1.9% | ||
| Q3 24 | 0.6% | 1.9% | ||
| Q2 24 | 0.6% | 1.3% | ||
| Q1 24 | 0.6% | 3.1% |
| Q4 25 | — | — | ||
| Q3 25 | 1.13× | — | ||
| Q2 25 | 0.57× | 0.19× | ||
| Q1 25 | 1.28× | 0.44× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.08× | — | ||
| Q2 24 | 0.53× | -0.28× | ||
| Q1 24 | 2.04× | 1.12× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CDW
Segment breakdown not available.
GEHC
| Imaging Segment | $2.6B | 45% |
| PCS Segment | $824.0M | 14% |
| P Dx Segment | $790.0M | 14% |
| Specialized Ultrasound Subsegment | $735.0M | 13% |
| Monitoring Solutions Subsegment | $578.0M | 10% |
| Life Support Solutions Subsegment | $247.0M | 4% |
